Corti Ships Symphony for Medical Coding with more than 25% Accuracy Edge Over OpenAI and Anthropic
Symphony for Medical Coding delivers production-ready medical coding automation across the US and Europe, based on learnings from the largest study of its kind. NEW YORK and COPENHAGEN, Denmark, April 1, 2026 /PRNewswire/ -- Corti, the frontier lab for clinical-grade AI, today released Symphony for Medical Coding, an agentic model that outperforms...
MedJ Unveils International Platform: Your Trusted Gateway to China’s Fast-Growing Biomedical Landscape
SHANGHAI, April 1, 2026 /PRNewswire/ -- MedJ, China's leading medical media platform, today officially launched its dedicated International Platform: a first-of-its-kind authoritative English-language hub delivering real-time, contextualized insights into China's fast-evolving healthcare and biomedical landscape for clinicians, researchers, and industry stakeholders worldwide. The launch comes as China's global influence in biomedical research reaches...
PATIENT TRUST AND QUALITY CARE DRIVE MALAYSIA’S GROWING HEALTHCARE REPUTATION
KUALA LUMPUR, Malaysia, April 1, 2026 /PRNewswire/ -- As Malaysia's healthcare ecosystem continues to strengthen its reputation for quality and innovation, Pantai Hospital Kuala Lumpur (PHKL), part of the IHH Healthcare multinational network has been recognised as one of the World's Best Hospitals for 2026 by Newsweek. The recognition reflects not only clinical excellence, but also the growing trust patients...
Abbisko Therapeutics’ FGFR4 Inhibitor Irpagratinib Granted Orphan Drug Designation by EMA for Hepatocellular Carcinoma
SHANGHAI, April 1, 2026 /PRNewswire/ -- 31 March 2026, Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256) announced that its independently developed, highly selective, oral small-molecule FGFR4 inhibitor irpagratinib (ABSK-011), has been granted Orphan Drug Designation (ODD) by the European Medicines Agency (EMA) for the treatment of hepatocellular carcinoma (HCC). Irpagratinib is...
NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development
PRINCETON, N.J. and TOKYO, April 1, 2026 /PRNewswire/ -- NJ Bio, Inc. ("NJ Bio"), a leading provider of integrated drug discovery and development services and Ajinomoto Bio‑Pharma Services ("Aji Bio‑Pharma"), a leading provider of biopharmaceutical manufacturing services and platform technologies, today announced a research collaboration to expand access to AJICAP™, Aji Bio‑Pharma's site‑specific conjugation platform for NJ Bio's discovery‑stage...
Tycoon Group Achieves Turnaround to Profit in 2025 Annual Results, Net Profit Surging 1.5 Times YoY
Growth Engines Running at Full Capacity,Leading the Charge in Southeast Asia's Blue Ocean Market Results Highlights In 2025, the local retail industry still facing challenges such as changes in consumer spending patterns, as well as pressures from rising rental costs and operational expenses. Despite the challenging operating environment, the Group has maintained its resilience in adversity by closely...
As the World “Looks East”: Chinese Companies Emerge as Global Connectors of Innovation
NEW YORK, March 31, 2026 /PRNewswire/ -- When German Chancellor Olaf Scholz called on the country's industrial sector to boost productivity, citing lessons from China, in the spring of 2026, the Western world's perception of "China's solutions" was already undergoing a profound shift. Over the past two years, from the large-scale rollout of robotaxis on city streets, to fully automated...
Samsung Biologics completes acquisition of GSK’s manufacturing facility in Rockville, Maryland
Adds 60,000 liters of drug substance capacity, bringing the total to 845,000 liters Marks Samsung Biologics' geographical diversification and establishes its first U.S. manufacturing presence, expanding regional client support Plans further investments to add capabilities and strengthen long-term operations at the Rockville site INCHEON, South Korea and ROCKVILLE, MD., March...
Dalton Pharma Services Expands Aseptic Powder Fill-Finish Capacity with RoboFil™ system in Toronto
A fully automated aseptic fill-finish platform delivers greater speed, flexibility, and quality for the manufacturing of clinical supplies and commercial products. TORONTO, March 31, 2026 /PRNewswire/ -- Dalton Pharma Services today announced the successful installation of its RoboFil™ aseptic powder fill-finish system at its Toronto, Canada facility. This fully automated, isolator-based platform expands...
New General Level Health Claim for Soy in Australia and New Zealand
New Claim Reaffirms the Positive Role of Soy Protein for Heart Health CHESTERFIELD, Mo., March 31, 2026 /PRNewswire/ -- The U.S. Soybean Export Council (USSEC) and Soy Nutrition Institute Global (SNI Global) applaud a new general level soy heart health claim in Australia and New Zealand.1 Similar claims already exist in the United...
